Redeye’s estimates were very much in line with Bong’s aggregated Q4-numbers. We note encouraging gross margins and Light Packaging sales. This is however balanced by higher SG&A costs and earnings (excluding goodwill amortization) were virtually as expected. We remain cautiously optimistic on Bong’s prospects for a gradual recovery in 2021.